| Literature DB >> 17145607 |
Wilma Barcellini1, Silvana Capalbo, Rosa Maria Agostinelli, Francesca Romana Mauro, Achille Ambrosetti, Rossella Calori, Agostino Cortelezzi, Luca Laurenti, Enrico Maria Pogliani, Paola Pedotti, Vincenzo Liso, Gabriella Girelli, Franco Mandelli, Alberto Zanella.
Abstract
The aim of this multicenter GIMEMA study was to correlate autoimmune complications (AIC) in B-cell chronic lymphocytic leukemia (B-CLL) with stage and therapy. Autoimmune hemolytic anemia (129/194 cases) and autoimmune thrombocytopenia (35/194 cases) were typically present in advanced and multi-treated disease. Age over the median, stage C and first and second line therapy were identified as independent risk factors by multivariate analysis. In contrast, non-hematologic AIC (30/194 cases) and the presence of serological markers of autoimmunity were mostly observed in early B-CLL, suggesting different pathogenic mechanisms underlying hematologic and non-hematologic autoimmune phenomena in B-CLL.Entities:
Mesh:
Substances:
Year: 2006 PMID: 17145607
Source DB: PubMed Journal: Haematologica ISSN: 0390-6078 Impact factor: 9.941